Published in PLoS One on April 12, 2013
Review of fluorescence guided surgery visualization and overlay techniques. Biomed Opt Express (2015) 0.97
Tumor endothelial marker imaging in melanomas using dual-tracer fluorescence molecular imaging. Mol Imaging Biol (2013) 0.90
Augmented microscopy: real-time overlay of bright-field and near-infrared fluorescence images. J Biomed Opt (2015) 0.81
Tomography of epidermal growth factor receptor binding to fluorescent Affibody in vivo studied with magnetic resonance guided fluorescence recovery in varying orthotopic glioma sizes. J Biomed Opt (2015) 0.80
Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy. Theranostics (2016) 0.77
Image-derived arterial input function for quantitative fluorescence imaging of receptor-drug binding in vivo. J Biophotonics (2015) 0.77
Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions. Mol Imaging Biol (2017) 0.76
Intraoperative Fluorescence Imaging for Personalized Brain Tumor Resection: Current State and Future Directions. Front Surg (2016) 0.75
Simultaneous in vivo fluorescent markers for perfusion, protoporphyrin metabolism and EGFR expression for optically guided identification of orthotopic glioma. Clin Cancer Res (2016) 0.75
Affibody molecules as engineered protein drugs. Exp Mol Med (2017) 0.75
Agents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical results. Acta Neurochir (Wien) (2016) 0.75
Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use. Mol Imaging Biol (2016) 0.75
In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor. Sci Rep (2016) 0.75
Synthesis of BODIPY-Peptide Conjugates for Fluorescence Labeling of EGFR Overexpressing Cells. Bioconjug Chem (2017) 0.75
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol (2006) 11.56
Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature (1985) 8.23
Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A (1987) 7.12
Engineered antibody fragments and the rise of single domains. Nat Biotechnol (2005) 6.96
Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med (1991) 5.33
Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery (2008) 5.03
Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg (2000) 3.83
Engineering novel binding proteins from nonimmunoglobulin domains. Nat Biotechnol (2005) 3.67
Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin Cancer Res (1995) 3.20
Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg (2011) 2.86
Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab (1996) 2.66
Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas. J Neurosurg (2011) 2.54
Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm. J Clin Oncol (2007) 2.09
The clinical use of fluorescein in neurosurgery; the localization of brain tumors. J Neurosurg (1948) 1.97
Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. FEBS Lett (2010) 1.85
Indocyanine green (ICG) staining and demarcation of tumor margins in a rat glioma model. Surg Neurol (1993) 1.72
Detecting epidermal growth factor receptor tumor activity in vivo during cetuximab therapy of murine gliomas. Acad Radiol (2009) 1.67
Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg (1993) 1.64
A structure-based model for ligand binding and dimerization of EGF receptors. Proc Natl Acad Sci U S A (2004) 1.62
Diffusion of epidermal growth factor in rat brain extracellular space measured by integrative optical imaging. J Neurophysiol (2004) 1.60
Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry. J Nucl Med (2009) 1.54
Epidermal growth factor receptor biology (IMC-C225). Curr Opin Oncol (2001) 1.42
Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. J Neurosurg (2003) 1.39
The biological properties of cetuximab. Crit Rev Oncol Hematol (2008) 1.31
Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature. Brain Pathol (2008) 1.28
Fluorescence-guided resections of malignant gliomas--an overview. Acta Neurochir Suppl (2003) 1.27
In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B (1998) 1.25
Combined fluorescence and reflectance spectroscopy for in vivo quantification of cancer biomarkers in low- and high-grade glioma surgery. J Biomed Opt (2011) 1.23
Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier. MAbs (2011) 1.20
Pathophysiology of heme synthesis. Semin Hematol (1988) 1.19
Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule. J Mol Biol (2008) 1.19
Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. Neurol Med Chir (Tokyo) (2007) 1.17
Quantitative, spectrally-resolved intraoperative fluorescence imaging. Sci Rep (2012) 1.17
Positive progress in immunoPET--not just a coincidence. Cancer Biother Radiopharm (2010) 1.14
The EGF receptor system as a target for antitumor therapy. Cancer Invest (1991) 1.11
Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect. J Neurosurg (1987) 1.11
Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma. Cancer Immunol Immunother (1993) 1.10
High vascular delivery of EGF, but low receptor binding rate is observed in AsPC-1 tumors as compared to normal pancreas. Mol Imaging Biol (2012) 1.08
Porphyrin metabolism in some malignant diseases. Br J Cancer (1992) 1.07
Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule. Nucl Med Biol (2007) 1.06
Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer (1995) 1.03
Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model. Photochem Photobiol (2009) 0.91
Intraoperative navigation and fluorescence imagings in malignant glioma surgery. Keio J Med (2008) 0.85
Diagnostic detection of diffuse glioma tumors in vive with molecular fluorescent probe-based transmission spectroscopy. Med Phys (2009) 0.84
Plasma drug concentrations: description and interpretation of the biexponential decay. Br J Anaesth (1993) 0.77
Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction. Commun Numer Methods Eng (2008) 3.87
Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications. J Photochem Photobiol B (2009) 3.31
Electromagnetic breast imaging: results of a pilot study in women with abnormal mammograms. Radiology (2007) 3.29
Assessing the future of diffuse optical imaging technologies for breast cancer management. Med Phys (2008) 3.02
Imaging breast adipose and fibroglandular tissue molecular signatures by using hybrid MRI-guided near-infrared spectral tomography. Proc Natl Acad Sci U S A (2006) 2.56
Multiwavelength three-dimensional near-infrared tomography of the breast: initial simulation, phantom, and clinical results. Appl Opt (2003) 2.54
Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation (2002) 2.49
Magnetic resonance-coupled fluorescence tomography scanner for molecular imaging of tissue. Rev Sci Instrum (2008) 2.46
Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes. Radiology (2009) 2.45
Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev (2010) 2.44
Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography. Proc Natl Acad Sci U S A (2003) 2.34
Image-guided optical spectroscopy provides molecular-specific information in vivo: MRI-guided spectroscopy of breast cancer hemoglobin, water, and scatterer size. Opt Lett (2007) 2.34
Image-guided diffuse optical fluorescence tomography implemented with Laplacian-type regularization. Opt Express (2007) 2.29
Near-infrared imaging in the small animal brain: optimization of fiber positions. J Biomed Opt (2003) 2.20
Spectrally resolved bioluminescence optical tomography. Opt Lett (2006) 2.14
Three-dimensional optical tomography: resolution in small-object imaging. Appl Opt (2003) 2.08
Tutorial on diffuse light transport. J Biomed Opt (2008) 1.92
Electromagnetic breast imaging: average tissue property values in women with negative clinical findings. Radiology (2004) 1.85
Combining near-infrared tomography and magnetic resonance imaging to study in vivo breast tissue: implementation of a Laplacian-type regularization to incorporate magnetic resonance structure. J Biomed Opt (2005) 1.84
A microcomputed tomography guided fluorescence tomography system for small animal molecular imaging. Rev Sci Instrum (2009) 1.83
Near-infrared characterization of breast tumors in vivo using spectrally-constrained reconstruction. Technol Cancer Res Treat (2005) 1.81
Cerenkov emission induced by external beam radiation stimulates molecular fluorescence. Med Phys (2011) 1.78
Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Mol Cancer Ther (2006) 1.71
Spectrally constrained chromophore and scattering near-infrared tomography provides quantitative and robust reconstruction. Appl Opt (2005) 1.68
Estimation of subcellular particle size histograms with electron microscopy for prediction of optical scattering in breast tissue. J Biomed Opt (2007) 1.68
Weight-matrix structured regularization provides optimal generalized least-squares estimate in diffuse optical tomography. Med Phys (2007) 1.68
Detecting epidermal growth factor receptor tumor activity in vivo during cetuximab therapy of murine gliomas. Acad Radiol (2009) 1.67
The effects of internal refractive index variation in near-infrared optical tomography: a finite element modelling approach. Phys Med Biol (2003) 1.65
Structural information within regularization matrices improves near infrared diffuse optical tomography. Opt Express (2007) 1.63
Subsurface diffuse optical tomography can localize absorber and fluorescent objects but recovered image sensitivity is nonlinear with depth. Appl Opt (2007) 1.60
In vivo hemoglobin and water concentrations, oxygen saturation, and scattering estimates from near-infrared breast tomography using spectral reconstruction. Acad Radiol (2006) 1.50
In vivo quantification of tumor receptor binding potential with dual-reporter molecular imaging. Mol Imaging Biol (2012) 1.49
Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications. Clin Cancer Res (2006) 1.49
Noninvasive Raman tomographic imaging of canine bone tissue. J Biomed Opt (2008) 1.49
Fast segmentation and high-quality three-dimensional volume mesh creation from medical images for diffuse optical tomography. J Biomed Opt (2013) 1.46
Time-gated Cherenkov emission spectroscopy from linear accelerator irradiation of tissue phantoms. Opt Lett (2012) 1.44
Numerical modelling and image reconstruction in diffuse optical tomography. Philos Trans A Math Phys Eng Sci (2009) 1.44
Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells. J Clin Invest (2008) 1.43
Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr (2006) 1.41
Spectral priors improve near-infrared diffuse tomography more than spatial priors. Opt Lett (2005) 1.35
Automated region detection based on the contrast-to-noise ratio in near-infrared tomography. Appl Opt (2004) 1.32
Pretreatment photosensitizer dosimetry reduces variation in tumor response. Int J Radiat Oncol Biol Phys (2006) 1.31
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer. Clin Cancer Res (2007) 1.27
Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res (2010) 1.27
Projection imaging of photon beams by the Čerenkov effect. Med Phys (2013) 1.24
Methodology development for three-dimensional MR-guided near infrared spectroscopy of breast tumors. Opt Express (2008) 1.24
Ionizing radiation increases systemic nanoparticle tumor accumulation. Nanomedicine (2012) 1.23
Quantitative imaging of scattering changes associated with epithelial proliferation, necrosis, and fibrosis in tumors using microsampling reflectance spectroscopy. J Biomed Opt (2009) 1.23
Contrast-detail analysis characterizing diffuse optical fluorescence tomography image reconstruction. J Biomed Opt (2005) 1.23
In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography. Med Phys (2010) 1.23
A boundary element approach for image-guided near-infrared absorption and scatter estimation. Med Phys (2007) 1.22
Imaging of glioma tumor with endogenous fluorescence tomography. J Biomed Opt (2009) 1.20
Early-photon fluorescence tomography: spatial resolution improvements and noise stability considerations. J Opt Soc Am A Opt Image Sci Vis (2009) 1.19
Imaging targeted-agent binding in vivo with two probes. J Biomed Opt (2010) 1.17
Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study. J Magn Reson Imaging (2002) 1.16
Imaging workflow and calibration for CT-guided time-domain fluorescence tomography. Biomed Opt Express (2011) 1.16
Spectral discrimination of breast pathologies in situ using spatial frequency domain imaging. Breast Cancer Res (2013) 1.16
Tumor angiogenesis change estimated by using diffuse optical spectroscopic tomography: demonstrated correlation in women undergoing neoadjuvant chemotherapy for invasive breast cancer? Radiology (2011) 1.14
Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography. J Biomed Opt (2006) 1.12
Critical computational aspects of near infrared circular tomographic imaging: Analysis of measurement number, mesh resolution and reconstruction basis. Opt Express (2006) 1.11
Scatter spectroscopic imaging distinguishes between breast pathologies in tissues relevant to surgical margin assessment. Clin Cancer Res (2012) 1.11
Spectrally resolved bioluminescence tomography using the reciprocity approach. Med Phys (2008) 1.11
Fluorescence tomography characterization for sub-surface imaging with protoporphyrin IX. Opt Express (2008) 1.11
Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models. Int J Radiat Oncol Biol Phys (2010) 1.09
Photobleaching-based dosimetry predicts deposited dose in ALA-PpIX PDT of rodent esophagus. Photochem Photobiol (2007) 1.09
High vascular delivery of EGF, but low receptor binding rate is observed in AsPC-1 tumors as compared to normal pancreas. Mol Imaging Biol (2012) 1.08
Čerenkov radiation emission and excited luminescence (CREL) sensitivity during external beam radiation therapy: Monte Carlo and tissue oxygenation phantom studies. Biomed Opt Express (2012) 1.08
Protoporphyrin IX level correlates with number of mitochondria, but increase in production correlates with tumor cell size. Photochem Photobiol (2007) 1.08
Magnetic-resonance-imaging-coupled broadband near-infrared tomography system for small animal brain studies. Appl Opt (2005) 1.07
Improved tumor contrast achieved by single time point dual-reporter fluorescence imaging. J Biomed Opt (2012) 1.07
Approximation of Mie scattering parameters in near-infrared tomography of normal breast tissue in vivo. J Biomed Opt (2005) 1.06
Toward whole-body optical imaging of rats using single-photon counting fluorescence tomography. Opt Lett (2011) 1.06
Automatic exposure control and estimation of effective system noise in diffuse fluorescence tomography. Opt Express (2009) 1.06
The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin Cancer Res (2003) 1.04
Superficial dosimetry imaging of Čerenkov emission in electron beam radiotherapy of phantoms. Phys Med Biol (2013) 1.04
System analysis of spatial frequency domain imaging for quantitative mapping of surgically resected breast tissues. J Biomed Opt (2013) 1.03
Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Int J Radiat Oncol Biol Phys (2005) 1.03
Human bronchial epithelial cells express and secrete MMP-12. Biochem Biophys Res Commun (2004) 1.03
Hybrid photomultiplier tube and photodiode parallel detection array for wideband optical spectroscopy of the breast guided by magnetic resonance imaging. J Biomed Opt (2014) 1.03
Pulsed-light imaging for fluorescence guided surgery under normal room lighting. Opt Lett (2013) 1.02
MRI-coupled fluorescence tomography quantifies EGFR activity in brain tumors. Acad Radiol (2010) 1.02
Liposomal delivery of photosensitising agents. Expert Opin Drug Deliv (2005) 1.01